Company Description

ILiAD Biotechnologies is a clinical stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis. Their lead candidate, BPZE1, is the most advanced next generation pertussis vaccine, having completed four Phase 2 clinical trials.